COMPASS THERAPEUTICS INC (CMPX) Stock Analyst Earnings Estimates
NASDAQ:CMPX - Nasdaq - US20454B1044 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 850K | -100.00% | 28.154M | 103.8M 268.69% | 224.58M 116.36% | 391.57M 74.36% | 688.56M 75.85% | 1.718B 149.51% | 2.74B 59.49% | |||
| EBITDA YoY % growth | -40.88M 49.72% | -49.664M -21.49% | -56.036M -12.83% | -79.254M -41.43% | -93.432M -17.89% | -80.58M 13.76% | 19.742M 124.50% | 141.11M 614.77% | 231.75M 64.23% | N/A | N/A | |
| EBIT YoY % growth | -41.66M 49.12% | -50.363M -20.89% | -56.625M -12.43% | -77.521M -36.90% | -99.287M -28.08% | -60.477M 39.09% | 53.073M 187.76% | 165.34M 211.53% | 418.28M 152.98% | 1.375B 228.73% | 2.294B 66.84% | |
| Operating Margin | N/A | N/A | -6,661.76% | N/A | -352.66% | -58.26% | 23.63% | 42.22% | 60.75% | 80.03% | 83.72% | |
| EPS YoY % growth | -0.37 69.70% | -0.34 8.11% | -0.37 -8.82% | -0.51 -38.22% | -0.57 -10.67% | -0.40 29.27% | 0.18 145.35% | 0.81 345.22% | 2.38 194.32% | 6.12 157.09% | 8.77 43.30% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 -26.48% | -0.13 -66.90% | -0.13 -14.98% | -0.13 -4.72% | -0.12 3.23% | -0.14 -3.13% | -0.12 7.26% |
| Revenue Q2Q % growth | -100.00% | N/A | 2.806M | 12.65M | |||
| EBITDA Q2Q % growth | -19.304M -30.97% | -21.17M -79.56% | -22.68M -41.88% | -23.786M -36.77% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.763M -24.71% | -19.577M -59.96% | -20.715M -24.99% | -19.262M -15.96% | -17.757M 5.37% | -22.128M -13.03% | -17.708M 14.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.12 -50.00% | -0.11 | -0.01 | -5.99% |
| Q4 2024 Q2Q % growth | -0.11 | -0.10 | -0.01 | -9.93% |
| Q3 2024 Q2Q % growth | -0.08 | -0.12 | 0.04 | 30.79% |
| Q2 2024 Q2Q % growth | -0.10 -11.11% | -0.10 | 0.00 | -3.20% |
| Q1 2024 Q2Q % growth | -0.08 -33.33% | -0.12 | 0.04 | 30.51% |
| Q4 2023 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -14.56% |
| Q3 2023 Q2Q % growth | -0.08 33.33% | -0.11 | 0.03 | 26.80% |
| Q2 2023 Q2Q % growth | -0.09 -12.50% | -0.08 | -0.01 | -8.36% |
| Q1 2023 Q2Q % growth | -0.06 14.29% | -0.11 | 0.05 | 45.82% |
| Q4 2022 Q2Q % growth | -0.10 52.38% | -0.11 | 0.01 | 12.85% |
| Q3 2022 Q2Q % growth | -0.12 -20.00% | -0.11 | -0.01 | -10.29% |
| Q2 2022 Q2Q % growth | -0.08 | -0.09 | 0.01 | 6.95% |
| Q1 2022 Q2Q % growth | -0.07 | -0.11 | 0.04 | 37.61% |
| Q4 2021 Q2Q % growth | -0.21 | -0.07 | -0.14 | -182.57% |
| Q3 2021 Q2Q % growth | -0.10 | -0.13 | 0.03 | 21.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -0.91% | -0.19% | -7.97% |
| Revenue | N/A | N/A | N/A | -100% |